Tian Xutengyue, Wang Jiayi, Jiang Lanxin, Jiang Yuchen, Xu Juan, Feng Xiaodong
State Key Laboratory of Oral Diseases, National Clinical Research Center for Oral Diseases, Research Unit of Oral Carcinogenesis and Management, Chinese Academy of Medical Sciences, West China Hospital of Stomatology, Sichuan University, Chengdu, Sichuan 610041, China.
Department of Stomatology, Sijing Hospital, Shanghai 210061, China.
J Oncol. 2022 Oct 11;2022:2208176. doi: 10.1155/2022/2208176. eCollection 2022.
Metastasis, the chief cause of cancer-related deaths, is associated with epithelial-mesenchymal transition (EMT). In the tumor microenvironment, EMT can be triggered by chemokine/G-protein-coupled receptor (GPCR) signaling, which is closely associated with tumor progression. However, the functional links between chemokine/GPCR signaling-mediated EMT and metastasis remain unclear. Herein, we summarized the mechanisms of chemokine/GPCR signaling-mediated EMT with an insight into facilitating metastasis and clarified the role of chemokine in the local invasion, intravasation, circulation, extravasation, and colonization, respectively. Moreover, several potential pathways that might contribute to EMT based on the latest studies on GPCR signaling were proposed, including signaling mediated by G protein, -arrestin, intracellular, dimerization activation, and transactivation. However, there is still limited evidence to support the EMT programme functional contribution to metastasis, which keeps a key question still open whether we should target EMT programme of cancer cells. Answers to that question might help develop an anticancer strategy or guide new directions for anticancer metastasis therapy.
转移是癌症相关死亡的主要原因,与上皮-间质转化(EMT)有关。在肿瘤微环境中,EMT可由趋化因子/G蛋白偶联受体(GPCR)信号传导触发,这与肿瘤进展密切相关。然而,趋化因子/GPCR信号传导介导的EMT与转移之间的功能联系仍不清楚。在此,我们总结了趋化因子/GPCR信号传导介导EMT促进转移的机制,并分别阐明了趋化因子在局部侵袭、血管内渗、循环、血管外渗和定植中的作用。此外,基于对GPCR信号传导的最新研究,提出了几种可能导致EMT的潜在途径,包括由G蛋白、β-抑制蛋白、细胞内、二聚化激活和反式激活介导的信号传导。然而,仍有有限的证据支持EMT程序对转移的功能贡献,这使得一个关键问题仍然悬而未决,即我们是否应该针对癌细胞的EMT程序。对该问题的回答可能有助于制定抗癌策略或为抗癌转移治疗指引新方向。